Pre-Open Stock Movers 04/09: (CELC) (AFMD) (GLSI) Higher; (PRVB) (ITRM) (JKS) Lower (more...)
- Stocks close with gains, led by Dow as investors look for rate insight
- Piper Sandler: Stock rally likely to continue on rising recession risks
- Robinhood (HOOD) rises after saying it plans to launch a credit card for US consumers
- Short sellers target Reddit shares as stock slips
- RH touts 'exceptional' demand for new collections after Q4 results fall short
- Discover Financial Services (DFS) Announces CEO Resignation
- Timken (TKR) Appoints Tarak Mehta as New CEO
- Crude Inventory Increases 3.2 Million Barrels
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Fisker (FSR) Cuts US Prices of Ocean SUV Up to 39% - Bloomberg
Greenwich LifeSciences (GLSI) Reports Poster Publication of Final 5-Yr GP2 Phase IIb Clinical Trial Immune Response Data
April 12, 2021 6:14 AM EDTGreenwich LifeSciences, Inc. (NASDAQ: GLSI) (the Company), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today presented a poster of the final 5 year GP2 Phase IIb clinical trial immune response data at the 2021 AACR Annual Meeting. Immune response is the primary mechanism of action for GP2 and is critical to developing dosing and booster treatment strategies that are designed to achieve and sustain peak immunity, as well as to prevent metastatic breast cancer recurrences.
It has been... More
fuboTV Inc. (FUBO) Extends Gain, Up 15%
April 9, 2021 10:44 AM EDTfuboTV Inc. (NYSE: FUBO) Extends Gain, Up 15%